Evaluation of a multimodal analgesic regimen on outcomes following laparoscopic living donor nephrectomy
- 8 April 2021
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 35 (8) , e14311
Abstract
Postoperative pain is a significant source of morbidity in patients undergoing living donor nephrectomy (LDN) and a deterrent for candidates. We implemented a standardized multimodal analgesic regimen, which consists of pharmacist‐led pre‐procedure pain management education, a combination transversus abdominis plane and rectus sheath block performed by the regional anesthesia team, scheduled acetaminophen and gabapentin, and as‐needed opioids. This single‐center retrospective study evaluated outcomes between patients undergoing LDN who received a multimodal analgesic regimen and a historical cohort. The multimodal cohort had a significantly shorter length of stay (LOS) (days, mean ± SD: 1.8 ± 0.7 vs. 2.6 ± 0.8; p < .001) and a greater proportion who were discharged on postoperative day (POD) 1 (38.6% vs. 1.5%; p < .001). The total morphine milligram equivalents (MME) that patients received during hospitalization were significantly less in the multimodal cohort on POD 0‐2. The outpatient MME prescribed through POD 60 was also significantly less in the multimodal cohort (median [IQR]; 180 [150‐188] vs. 225 [150‐300]; p < .001). The mean patient‐reported pain score (PRPS) was significantly lower in the multimodal cohort on POD 0‐2. The maximum PRPS was significantly lower on POD 0 (mean ± SD: 7 ± 2 vs. 8 ± 1, respectively; p = .02). This study suggests that our multimodal regimen significantly reduces LOS, PRPS, and opioid requirements and has the potential to improve the donation experience.Keywords
This publication has 24 references indexed in Scilit:
- Perioperative Ketorolac Use: A Potential Risk Factor for Renal Dysfunction After Live-Donor NephrectomyAnnals of Transplantation, 2017
- Pregabalin reduces opioid consumption and hyperalgesia but not pain intensity after laparoscopic donor nephrectomyActa Anaesthesiologica Scandinavica, 2017
- Clinical safety and effectiveness of transversus abdominis plane (TAP) block in post-operative analgesia: a systematic review and meta-analysisJournal of Anesthesia, 2017
- Ultrasound‐guided subcostal transversus abdominis plane blocks with liposomal bupivacaine vs. non‐liposomal bupivacaine for postoperative pain control after laparoscopic hand‐assisted donor nephrectomy: a prospective randomised observer‐blinded studyAnaesthesia, 2016
- Ultrasound-guided rectus sheath and transversus abdominis plane blocks for perioperative analgesia in upper abdominal surgery: A randomized controlled studySaudi Journal of Anaesthesia, 2016
- Randomized Clinical Trial of Transversus Abdominis Plane Block Versus Placebo Control in Live-Donor NephrectomyTransplantation, 2012
- Effect of adding dexamethasone to bupivacaine on transversus abdominis plane block for abdominal hysterectomy: A prospective randomized controlled trialSaudi Journal of Anaesthesia, 2012
- Continuous Infusion of Local Anesthesia After Living Donor Nephrectomy: A Comparative AnalysisTransplantation Proceedings, 2011
- Patients' Willingness to Talk to others about Living Kidney DonationProgress in Transplantation, 2008
- Opioids in Neuropathic PainCurrent Pharmaceutical Design, 2005